PMID- 33520828 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20220420 IS - 2251-6581 (Print) IS - 2251-6581 (Electronic) IS - 2251-6581 (Linking) VI - 19 IP - 2 DP - 2020 Dec TI - Medication non-adherence in patients with type 2 diabetes mellitus with full access to medicines. PG - 1105-1113 LID - 10.1007/s40200-020-00612-2 [doi] AB - PURPOSE: The pharmacological treatment for Type 2 diabetes mellitus (T2DM) is continuous and adherence to medication is critical for disease control. Restricted access to medicines is one of the most important barriers to adherence to T2DM treatment. This study aimed to evaluate other factors for medication non-adherence by studying patients with full access to oral hypoglycemic agents. METHODS: Cross-sectional study with 300 patients receiving their medication without costs from a referral center for diabetes care in Crato, Ceara (Brazil). Participants were recruited from January to December 2017. Information was obtained by self-applied questionnaires, and the drugs used were confirmed in the prescription. Adherence to medication was determined by the Morisky Medication Adherence Scale (MMAS-4). Patient perceptions of drugs were assessed by the Beliefs about Medicines Questionnaire (BMQ). RESULTS: Only 22.7% of participants met the criterion of high adherence to medication. The most frequent characteristics in the low adherence group were married; hypertension; no regular physical activity; therapy based on the combination of two or more oral antidiabetic agents without insulin; low score in the BMQ necessity scale. Necessity score in BMQ increased with age and the number of medications used and decreased if the patient had family members with the same disease and had children. CONCLUSIONS: Full access to medicines did not assure high adherence to pharmacological treatment of type 2 diabetes mellitus. Distinctive factors to medication non-adherence may be found and specific barriers should be considered when planning actions for improving adherence in such populations. CI - (c) Springer Nature Switzerland AG 2020. FAU - Saraiva, Emanuela Machado Silva AU - Saraiva EMS AD - Faculdade de Juazeiro do Norte (FJN), Juazeiro do Norte, Ceara Brazil. AD - Centro Universitario Saude ABC (CUSABC), Av Principe de Gales 821, Santo Andre, Sao Paulo CEP 09060 - 650 Brazil. GRID: grid.419034.b. ISNI: 0000 0004 0413 8963 FAU - Coelho, Jose Leonardo Gomes AU - Coelho JLG AD - Faculdade de Juazeiro do Norte (FJN), Juazeiro do Norte, Ceara Brazil. FAU - Dos Santos Figueiredo, Francisco Winter AU - Dos Santos Figueiredo FW AUID- ORCID: 0000-0002-9377-6443 AD - Centro Universitario Saude ABC (CUSABC), Av Principe de Gales 821, Santo Andre, Sao Paulo CEP 09060 - 650 Brazil. GRID: grid.419034.b. ISNI: 0000 0004 0413 8963 FAU - do Souto, Ricardo Peres AU - do Souto RP AUID- ORCID: 0000-0002-6281-5956 AD - Centro Universitario Saude ABC (CUSABC), Av Principe de Gales 821, Santo Andre, Sao Paulo CEP 09060 - 650 Brazil. GRID: grid.419034.b. ISNI: 0000 0004 0413 8963 LA - eng PT - Journal Article DEP - 20200813 PL - Switzerland TA - J Diabetes Metab Disord JT - Journal of diabetes and metabolic disorders JID - 101590741 PMC - PMC7843744 OTO - NOTNLM OT - Diabetes mellitus, type 2 OT - Medication adherence OT - Oral hypoglycemic agents OT - Primary health care COIS- Conflicts of interestThe authors declare no conflict of interest in this study. EDAT- 2021/02/02 06:00 MHDA- 2021/02/02 06:01 PMCR- 2021/08/13 CRDT- 2021/02/01 05:59 PHST- 2020/02/12 00:00 [received] PHST- 2020/07/23 00:00 [revised] PHST- 2020/08/10 00:00 [accepted] PHST- 2021/02/01 05:59 [entrez] PHST- 2021/02/02 06:00 [pubmed] PHST- 2021/02/02 06:01 [medline] PHST- 2021/08/13 00:00 [pmc-release] AID - 612 [pii] AID - 10.1007/s40200-020-00612-2 [doi] PST - epublish SO - J Diabetes Metab Disord. 2020 Aug 13;19(2):1105-1113. doi: 10.1007/s40200-020-00612-2. eCollection 2020 Dec.